Gilead Delayed Safer HIV Drug to Extend Monopoly Profits, Advocates Allege
Share
[aggregation-styles]
The Washington Post Subscription
The Washington Post Subscription
In 2005, Gilead Sciences notified federal regulators that it was suspending development of a potentially safer, more potent HIV-fighting drug than the one on the market. The company did not restart its Food and Drug Administration application until 2010. Now the five-year delay of a promising drug is at the core of accusations by advocates that Gilead improperly exploited the patent system at the expense of patient health.
An HIV-prevention group called PrEP4All Collaboration filed a petition Wednesday with the U.S. Patent and Trademark Office contending Gilead knew its new, improved drug — approved in 2015 and now part of Gilead’s combination therapies Genvoya and Descovy — was safer. But it alleged Gilead postponed development so it could continue to gain monopoly profits from its older combination HIV drugs, including Viread and Truvada, for a longer period,before those drugs went off patent and faced generic competition.
An HIV-prevention group called PrEP4All Collaboration filed a petition Wednesday with the U.S. Patent and Trademark Office contending Gilead knew its new, improved drug — approved in 2015 and now part of Gilead’s combination therapies Genvoya and Descovy — was safer. But it alleged Gilead postponed development so it could continue to gain monopoly profits from its older combination HIV drugs, including Viread and Truvada, for a longer period,before those drugs went off patent and faced generic competition.
By Christopher Rowland | 5 Dec 2019
RELATED TOPICS:
Mike Tyson-Jake Paul: How to Watch the Fight, Time, Odds
Sports /
3 hours ago
Travel in the West Bank Is a Tale of Two Journeys
World /
3 hours ago
Chris Wallace Is Leaving CNN, Eager to Explore New Media Landscape
Latest /
3 hours ago
Merced’s Iconic Laura Fountain Returns to Splendor With $300K Restoration
Local /
4 hours ago
Trump Picks Former Arkansas Gov. Mike Huckabee to Be Ambassador to Israel
Politics /
4 hours ago
Tulare Gang Member Gets Life Without Parole for 2022 Murders
Nathaniel Lujano, 23, of Tulare, was sentenced to life without parole for two murders the Tulare County District Attorney’s Office ann...
Crime /
58 mins ago
Categories
Latest
Videos
Crime /
58 mins ago
Tulare Gang Member Gets Life Without Parole for 2022 Murders
Politics /
2 hours ago
Will Trump Loyalist Devin Nunes Be Tapped to Head the CIA?
Sports /
3 hours ago
Mike Tyson-Jake Paul: How to Watch the Fight, Time, Odds
World /
3 hours ago
Travel in the West Bank Is a Tale of Two Journeys
Latest /
3 hours ago
Chris Wallace Is Leaving CNN, Eager to Explore New Media Landscape
Local /
4 hours ago
Merced’s Iconic Laura Fountain Returns to Splendor With $300K Restoration
Video /
6 days ago